6 days away from first patient dosing! Of course things are trending in the right direction.
I do not think they will have trouble finding 40 patients to complete trials in SK. I think it is a testament to their amazing healthcare system and how well they have handled the pandemic. Certainly. But all in all there are definitely 40 people in the country whose lungs or health has been impacted by the virus and will benefit from the use of Ifenprodil (one would think).
As it has been mentioned, highly likely Remdesivir is smoke and mirrors. US government appear to be more focused on making money and less about helping the people. Interesting yes one would wonder how many higher ups hold shares in Gilead. But that's neither here nor there. No data released for scientific minds to assess? Even the head medical professor at Yale sentiment 'a treatment? Great! Let us see the data?'. I mean it sounds like opinion but if one uses their intuition it seems its all there to be decoded for those who can see through the fog.
Algernon continues to plug away towards the main goal with real life data on the way. I see no signs of slowing down here. 5 million ready to go (more than likely to commence North American trials). 5 million to help pay for multi billion dollar data seems like a good deal to me and probably to Mackie as well. Getting ready for the ride of our lives.
Market Data 
Markets 
AI
